Skip to main content
Cardiolucent

Treatment

Anticoagulation (Warfarin, DOACs)

Choosing and managing the right blood thinner for stroke and clot prevention.

Anticoagulation lowers the chance of forming dangerous blood clots in patients with atrial fibrillation, mechanical heart valves, prior deep vein thrombosis or pulmonary embolism, and certain hypercoagulable conditions. The two main families of oral anticoagulants are warfarin, a vitamin K antagonist that has been in use for decades, and the direct oral anticoagulants (DOACs) — apixaban, rivaroxaban, dabigatran, and edoxaban — which directly inhibit specific clotting factors. Selecting between them requires balancing stroke or clot risk against bleeding risk and accounting for kidney function, drug interactions, and lifestyle. Dr. Kedan personally guides this decision and the ongoing management that follows.

What This Treatment Approach Includes

  • Side-by-side comparison of warfarin vs DOACs based on your indication, anatomy, and kidney function
  • Calculation of stroke risk (CHA2DS2-VASc) and bleeding risk (HAS-BLED) before starting therapy
  • Selection between apixaban, rivaroxaban, dabigatran, and edoxaban when a DOAC is appropriate
  • INR target setting and lab cadence when warfarin is the right choice
  • Periprocedural management — when to hold the anticoagulant and when to resume
  • Drug interaction screening with every medication change
  • Bleeding precaution education and direct access for urgent questions

How It Works

Warfarin blocks the liver's vitamin K-dependent production of clotting factors II, VII, IX, and X, requiring INR monitoring to keep the level in a therapeutic range. DOACs work downstream by directly inhibiting a single clotting factor — apixaban, rivaroxaban, and edoxaban inhibit factor Xa, while dabigatran inhibits thrombin (factor IIa) — which produces a predictable effect that does not require routine coagulation monitoring. Both approaches reduce the body's ability to form pathologic clots without eliminating the ability to stop bleeding.

Who This Is For

  • Non-valvular atrial fibrillation with elevated stroke risk — usually a DOAC
  • Mechanical heart valves — warfarin is required; DOACs are not appropriate
  • Moderate-to-severe mitral stenosis — warfarin preferred
  • Acute or recurrent deep vein thrombosis or pulmonary embolism
  • Severe kidney impairment, where warfarin may be safer than some DOACs
  • Patients who cannot tolerate or afford a specific DOAC and need an alternative
  • Periprocedural bridging considerations after planned procedures

Monitoring and Follow-Up

Warfarin requires regular INR checks — typically weekly during initiation and dose changes, then every few weeks once stable. DOACs do not require coagulation monitoring, but periodic kidney function, liver function, and complete blood counts are checked because dosing depends on renal clearance and any unexplained drop in hemoglobin warrants investigation. As a concierge practice, Cardiolucent coordinates same-day labs and direct phone access to Dr. Kedan so dose adjustments and bleeding concerns are resolved in real time rather than through portal messages.

How Cardiolucent Manages This

Dr. Kedan personally selects the anticoagulant, sets the monitoring cadence, and adjusts therapy as your kidney function, other medications, or procedures change. Extended visits allow shared decision-making about the tradeoffs between agents — including cost, dosing frequency, and lifestyle fit. Periprocedural management is coordinated directly with your surgeon or proceduralist, which is one of the most error-prone parts of anticoagulation care when it is left to a fragmented team.

Common Questions

Frequently Asked Questions

What is the practical difference between warfarin and a DOAC?
Warfarin is taken daily with regular INR blood tests and dose adjustments, has many food and drug interactions, but is inexpensive and has decades of safety data. DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) are taken at a fixed dose without routine blood monitoring, have fewer interactions, but are more expensive and have specific dosing rules based on kidney function. For most patients with non-valvular atrial fibrillation, a DOAC is preferred; for mechanical heart valves and certain other situations, warfarin is required.
Who is a candidate for a DOAC?
Most patients with non-valvular atrial fibrillation, treated deep vein thrombosis or pulmonary embolism, and many hypercoagulable conditions are appropriate DOAC candidates. The specific agent depends on your kidney function, other medications, dosing-frequency preference, and whether a reversal agent is important to you. Dr. Kedan walks through the comparison directly rather than defaulting to one product.
Why are mechanical heart valves still treated with warfarin?
Trials comparing DOACs to warfarin in patients with mechanical heart valves showed higher rates of clotting and bleeding on the DOAC, so warfarin remains the standard. If you have a bioprosthetic (tissue) valve, a DOAC may be appropriate depending on timing and rhythm. Anatomy drives the choice.
How is the right warfarin dose found?
Warfarin dosing is individualized using INR — your target is typically 2.0 to 3.0 for most indications, or 2.5 to 3.5 for some mechanical valves. Initiation involves frequent INR checks with small dose adjustments until you stabilize, then monitoring stretches to every two to four weeks. Many factors — diet, alcohol, illness, antibiotics — can shift your INR, which is why ongoing access matters.
What side effects should I watch for?
The main concern with any anticoagulant is bleeding — easy bruising, prolonged bleeding from small cuts, nosebleeds, gum bleeding, and heavier menstrual periods are common but usually manageable. More serious signs that require immediate attention include blood in the urine or stool (including black, tarry stools), coughing or vomiting blood, severe headache or vision change, and any significant trauma — especially head trauma. Specific patterns are discussed individually based on which agent you take.
What about reversal if I bleed or need emergency surgery?
Warfarin can be reversed with vitamin K, fresh frozen plasma, or prothrombin complex concentrate. Dabigatran has a specific reversal agent (idarucizumab); apixaban and rivaroxaban have a reversal agent (andexanet alfa) available at major centers including Cedars-Sinai. The availability of a reversal agent is one factor Dr. Kedan weighs in agent selection for higher-bleeding-risk patients.
How long will I be on anticoagulation?
For atrial fibrillation, mechanical valves, and recurrent unprovoked clots, anticoagulation is typically lifelong because the underlying risk does not resolve. A single provoked clot — after surgery, prolonged immobility, or a major medical illness — usually needs three to six months. Dr. Kedan revisits the duration question at every reassessment, especially as your kidney function, age, or bleeding risk evolves.
What medications and foods interact with these drugs?
Warfarin is sensitive to vitamin K intake (leafy greens) and to many antibiotics, antifungals, NSAIDs, and supplements — consistency matters more than avoidance. DOACs have fewer interactions but are affected by strong inducers and inhibitors of liver enzymes and P-glycoprotein, including certain seizure medications, antifungals, and HIV medications. Bring a complete list — including supplements — to every visit.
What happens with anticoagulation around surgery or dental work?
Periprocedural management is individualized to the procedure's bleeding risk and your clot risk. Most minor dental work does not require holding therapy; major surgery typically requires stopping the anticoagulant a defined number of days beforehand and resuming on a specific schedule afterward. Bridging with a short-acting injectable is rarely needed for DOACs but may be considered for some warfarin patients. Always notify Dr. Kedan as soon as a procedure is scheduled.
How do I start anticoagulation with Dr. Kedan?
Schedule a consultation at the Beverly Hills office to review your indication, kidney function, other medications, and preferences. Cardiolucent does not bill Medicare or insurance, though a detailed superbill is provided for out-of-network reimbursement. Call (310) 304-5555 or use the contact form.

Explore

Related Treatments

Choosing the right anticoagulant?

Discuss this treatment with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.